Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile Virus
Open Access
- 15 July 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 200 (2) , 202-205
- https://doi.org/10.1086/599794
Abstract
Previous studies have established the therapeutic efficacy of humanized E16 (hE16) monoclonal antibody against West Nile virus in animals. Here, we aKeywords
This publication has 14 references indexed in Scilit:
- The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus InfectionPublished by Elsevier ,2007
- Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral EvasionJournal of Virology, 2006
- Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile VirusJournal of Virology, 2006
- Structural basis of West Nile virus neutralization by a therapeutic antibodyNature, 2005
- Characterization of neutralizing antibodies to West Nile virusVirology, 2005
- Development of a humanized monoclonal antibody with therapeutic potential against West Nile virusNature Medicine, 2005
- Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strainsVirology, 2005
- Identification of Neutralizing Epitopes within Structural Domain III of the West Nile Virus Envelope ProteinJournal of Virology, 2002
- Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitisTransplant Infectious Disease, 2002
- Partial Genetic Characterization of West Nile Virus Strains, New York State, 2000Emerging Infectious Diseases, 2001